Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

T14.SG - Current Price

$3.32

Company Information

▼
Company Name
TIANJIN PHARM DA REN TANG GRP
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
SG
Currency: USD
Full Time Employees: 0
Phone: 86 22 2702 0598
Website: https://www.jydrt.com.cn
Fiscal Year End: December
Description:

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People's Republic of China.

Address:

Darentang Building, Tianjin, China, 300193

Directors & Officers

▼
Name Title Year Born
Ms. Lei Wang Chairman of the Board 1971
Mr. Jian Ma Chief Financial Officer 1978
Mr. Hong Zhou Deputy GM, Chief Engineer & Executive Director 1970
Mr. Min Guo Executive Director 1971
Mr. Yu Zhang Chief Manufacturing Officer 1973
Mr. Mingjie Shang Executive Director 1969
Ms. Yan Jiao Secretary to the Board of Directors 1977

Shares Statistics

▼
Shares Outstanding: 200.00M
Shares Float: 421.35M
% Insiders: 880.00%
% Institutions: 16.00%

Valuation Metrics

▼
Enterprise Value: $4.34B
Trailing P/E: 4.96
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $4.24B
EBITDA: $1.00B
P/E Ratio: $4.96
PEG Ratio: $0.00
Book Value: $1.68
Dividend/Share: $1.28
Dividend Yield: 38.67%
Earnings/Share: $0.67
Profit Margin: 66.68%
Operating Margin: 21.33%
ROA (TTM): 4.92%
ROE (TTM): 46.11%
Revenue (TTM): $5.37B
Revenue/Share (TTM): $7.01
Earnings Growth (YOY): 55.20%
Revenue Growth (YOY): -38.10%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Jun 30, 2023 0.06 N/A N/A N/A
Mar 31, 2023 0.08 N/A N/A N/A
Sep 30, 2022 0.34 N/A N/A N/A
Jun 30, 2022 0.35 N/A N/A N/A
Mar 31, 2022 0.04 N/A N/A N/A
Dec 31, 2021 0.14 N/A N/A N/A
Sep 30, 2021 0.04 N/A N/A N/A
Jun 30, 2021 0.05 N/A N/A N/A
Mar 31, 2021 0.04 N/A N/A N/A
Dec 31, 2020 0.04 N/A N/A N/A
Sep 30, 2020 0.03 N/A N/A N/A
Jun 30, 2020 0.03 N/A N/A N/A
Mar 31, 2020 0.23 N/A N/A N/A
Sep 30, 2019 0.02 N/A N/A N/A
Jun 30, 2019 0.03 N/A N/A N/A
Mar 31, 2019 0.04 N/A N/A N/A
Dec 31, 2018 0.03 N/A N/A N/A
Sep 30, 2018 0.11 N/A N/A N/A
Jun 30, 2018 0.18 N/A N/A N/A
Mar 31, 2018 0.04 N/A N/A N/A
Sep 30, 2017 0.02 N/A N/A N/A
Jun 30, 2017 0.03 N/A N/A N/A
Mar 31, 2017 0.03 N/A N/A N/A
Dec 31, 2016 0.01 N/A N/A N/A
Sep 30, 2016 0.02 N/A N/A N/A
Jun 30, 2016 0.03 N/A N/A N/A
Mar 31, 2016 0.02 N/A N/A N/A
Dec 31, 2015 0.02 N/A N/A N/A
Sep 30, 2015 0.02 N/A N/A N/A
Jun 30, 2015 0.03 N/A N/A N/A
Mar 31, 2015 0.03 N/A N/A N/A
Dec 31, 2014 0.02 N/A N/A N/A
Sep 30, 2014 0.01 N/A N/A N/A
Jun 30, 2014 0.02 N/A N/A N/A
Mar 31, 2014 0.02 N/A N/A N/A
Dec 31, 2013 0.03 N/A N/A N/A
Sep 30, 2013 0.01 N/A N/A N/A
Jun 30, 2013 0.02 N/A N/A N/A
Mar 31, 2013 0.03 N/A N/A N/A
Dec 31, 2012 0.02 N/A N/A N/A
Sep 30, 2012 0.01 N/A N/A N/A
Jun 30, 2012 0.04 N/A N/A N/A
Mar 31, 2012 0.03 N/A N/A N/A
Dec 31, 2011 0.00 N/A N/A N/A
Sep 30, 2011 0.01 N/A N/A N/A
Jun 30, 2011 0.02 N/A N/A N/A
Mar 31, 2011 0.02 N/A N/A N/A
Dec 31, 2010 0.01 N/A N/A N/A
Sep 30, 2010 0.01 N/A N/A N/A
Jun 30, 2010 0.03 N/A N/A N/A
Mar 31, 2010 0.02 N/A N/A N/A
Dec 31, 2009 0.01 N/A N/A N/A
Sep 30, 2009 0.01 N/A N/A N/A
Jun 30, 2009 0.01 N/A N/A N/A
Mar 31, 2009 0.02 N/A N/A N/A
Dec 31, 2008 0.00 N/A N/A N/A
Sep 30, 2008 0.01 N/A N/A N/A
Jun 30, 2008 0.02 N/A N/A N/A
Mar 31, 2008 0.01 N/A N/A N/A
Dec 31, 2007 -0.08 N/A N/A N/A
Sep 30, 2007 0.00 N/A N/A N/A
Jun 30, 2007 0.01 N/A N/A N/A
Mar 31, 2007 0.00 N/A N/A N/A
Dec 31, 2004 0.00 N/A N/A N/A
Jun 30, 2004 0.01 N/A N/A N/A
Dec 31, 2003 0.00 N/A N/A N/A
Jun 30, 2003 0.00 N/A N/A N/A
Mar 31, 2003 0.00 N/A N/A N/A
Dec 31, 2002 0.00 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $2.94B $N/A $10.77B $2.92B $7.84B
2023-12-31 $2.13B $N/A $10.23B $3.58B $6.60B
2022-12-31 $2.88B $N/A $10.16B $3.61B $6.52B
2021-12-31 $2.28B $N/A $9.07B $2.55B $6.36B
2020-12-31 $1.99B $N/A $8.28B $2.33B $5.81B
2019-12-31 $1.48B $N/A $7.84B $2.46B $5.39B
2018-12-31 $1.46B $N/A $7.11B $2.18B $4.93B
2017-12-31 $975.11M $N/A $6.62B $2.15B $4.48B
2016-12-31 $943.04M $N/A $6.44B $2.26B $4.18B
2015-12-31 $762.96M $N/A $6.07B $2.15B $3.92B
2014-12-31 $630.93M $N/A $5.44B $2.49B $2.76B
2013-12-31 $544.73M $N/A $5.26B $2.69B $2.42B

Watchlist

0

No stocks in watchlist